AMPA receptor downregulation induced by ischaemia/reperfusion is attenuated by age and blocked by meloxicam

Neuropathology and Applied Neurobiology

Volumn 36, Issue 5, 2010, Pages 436-447

  Montori, S ^a   Dosanjos, S ^a   Rios Granja M A ^a   Perez Garcia C C ^a   Fernandez Lopez A ^a   Martinez Villayandre B ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

ADAR2; age; AMPA receptor; CD11b; cerebral ischaemia; meloxicam

Indexed keywords

ADENOSINE DEAMINASE RECEPTOR 2; AMPA RECEPTOR; CD11B ANTIGEN; CD18 ANTIGEN; MELOXICAM; MESSENGER RNA; PROTEIN; PROTEIN GLUR 1; PROTEIN GLUR 2; UNCLASSIFIED DRUG; ADENOSINE DEAMINASE; BIOLOGICAL MARKER; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN REGION; DENTATE GYRUS; DOWN REGULATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; STROKE;

ADENOSINE DEAMINASE; AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD11B; BIOLOGICAL MARKERS; DOWN-REGULATION; GENE EXPRESSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; REPERFUSION INJURY; RNA, MESSENGER; STROKE; THIAZINES; THIAZOLES;

EID: 77954472007     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01086.x     Document Type: Article

References (67)

1. Fisher M, Bastan B. Treating acute ischemic stroke. Curr Opin Drug Discov Devel 2008 11 : 626 632
2. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke 2002 33 : 862 875
3. Ay H, Koroshetz WJ, Vangel M, Benner T, Melinosky C, Zhu M, Menezes N, Lopez CJ, Sorensen AG. Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005 36 : 2632 2636
4. Baltan S, Besancon EF, Mbow B, Ye Z, Hamner MA, Ransom BR. White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 2008 28 : 1479 1489
5. Schaller BJ. Influence of age on stroke and preconditioning-induced ischemic tolerance in the brain. Exp Neurol 2007 205 : 9 19
6. Barnett HJ. Stroke prevention in the elderly. Clin Exp Hypertens 2002 24 : 563 571
7. Muntner P, Garrett E, Klag MJ, Coresh J. Trends in stroke prevalence between 1973 and 1991 in the US population 25-74 years of age. Stroke 2002 33 : 1209 1213
8. Davolio C, Greenamyre JT. Selective vulnerability of the CA1 region of hippocampus to the indirect excitotoxic effects of malonic acid. Neurosci Lett 1995 192 : 29 32
9. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982 239 : 57 69
10. Kowalczyk JE, Beresewicz M, Gajkowska B, Zablocka B. Association of protein kinase C delta and phospholipid scramblase 3 in hippocampal mitochondria correlates with neuronal vulnerability to brain ischemia. Neurochem Int 2009 55 : 157 163
11. Yang G, Kitagawa K, Ohtsuki T, Kuwabara K, Mabuchi T, Yagita Y, Takazawa K, Tanaka S, Yanagihara T, Hori M, Matsumoto M. Regional difference of neuronal vulnerability in the murine hippocampus after transient forebrain ischemia. Brain Res 2000 870 : 195 198
12. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998 54 : 581 618
13. Stys PK. White matter injury mechanisms. Curr Mol Med 2004 4 : 113 130
14. Tekkok SB, Ye Z, Ransom BR. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007 27 : 1540 1552
15. Dos-Anjos S, Martinez-Villayandre B, Montori S, Regueiro-Purrinos MM, Gonzalo-Orden JM, Fernandez-Lopez A. Global ischemia-induced modifications in the expression of AMPA receptors and inflammation in rat brain. Brain Res 2009 1287 : 20 7
16. Friedman LK, Ginsberg MD, Belayev L, Busto R, Alonso OF, Lin B, Globus MY. Intraischemic but not postischemic hypothermia prevents non-selective hippocampal downregulation of AMPA and NMDA receptor gene expression after global ischemia. Brain Res Mol Brain Res 2001 86 : 34 47
17. Gorter JA, Petrozzino JJ, Aronica EM, Rosenbaum DM, Opitz T, Bennett MV, Connor JA, Zukin RS. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 1997 17 : 6179 6188
18. Hollmann M, Hartley M, Heinemann S. Ca2+ permeability of KA-AMPA - gated glutamate receptor channels depends on subunit composition. Science 1991 252 : 851 853
19. Soundarapandian MM, Tu WH, Peng PL, Zervos AS, Lu Y. AMPA receptor subunit GluR2 gates injurious signals in ischemic stroke. Mol Neurobiol 2005 32 : 145 155
20. Greger IH, Ziff EB, Penn AC. Molecular determinants of AMPA receptor subunit assembly. Trends Neurosci 2007 30 : 407 416
21. Borges K, Dingledine R. AMPA receptors: molecular and functional diversity. Prog Brain Res 1998 116 : 153 170
22. Rosenmund C, Stern-Bach Y, Stevens CF. The tetrameric structure of a glutamate receptor channel. Science 1998 280 : 1596 1599
23. Martin LJ, Blackstone CD, Levey AI, Huganir RL, Price DL. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 1993 53 : 327 358
24. Monyer H, Seeburg PH, Wisden W. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron 1991 6 : 799 810
25. Sans N, Vissel B, Petralia RS, Wang YX, Chang K, Royle GA, Wang CY, O'Gorman S, Heinemann SF, Wenthold RJ. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci 2003 23 : 9367 9373
26. Wenthold RJ, Petralia RS, Blahos J II., Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 1996 16 : 1982 1989
27. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997 20 : 464 470
28. Burnashev N, Monyer H, Seeburg PH, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992 8 : 189 198
29. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993 75 : 1361 1370
30. Tanaka H, Grooms SY, Bennett MV, Zukin RS. The AMPAR subunit GluR2: still front and center-stage. Brain Res 2000 886 : 190 207
31. Jonas P, Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 1995 15 : 987 990
32. Raza M, Deshpande LS, Blair RE, Carter DS, Sombati S, DeLorenzo RJ. Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons. Neurosci Lett 2007 418 : 77 81
33. Hajieva P, Kuhlmann C, Luhmann HJ, Behl C. Impaired calcium homeostasis in aged hippocampal neurons. Neurosci Lett 2009 451 : 119 123
34. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009 276 : 13 26
35. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999 19 : 819 834
36. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006 37 : 291 293
37. Feuerstein GZ, Wang X, Barone FC. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann N Y Acad Sci 1997 825 : 179 193
38. Rodriguez-Yanez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol 2008 21 : 353 357
39. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 2006 18 : 145 157
40. Taoufik E, Probert L. Ischemic neuronal damage. Curr Pharm Des 2008 14 : 3565 3573
41. Antezana DF, Clatterbuck RE, Alkayed NJ, Murphy SJ, Anderson LG, Frazier J, Hurn PD, Traystman RJ, Tamargo RJ. High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. J Neurosurg 2003 98 : 860 866
42. Cole DJ, Patel PM, Reynolds L, Drummond JC, Marcantonio S. Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume. J Pharmacol Exp Ther 1993 266 : 1713 1717
43. Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007 54 : 34 66
44. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997 17 : 2746 2755
45. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 1998 95 : 10966 10971
46. Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug. Clin Pharmacokinet 1999 36 : 115 126
47. Davis M, Mendelow AD, Perry RH, Chambers IR, James OF. Experimental stroke and neuroprotection in the aging rat brain. Stroke 1995 26 : 1072 1078
48. Gates BJ, Nguyen TT, Setter SM, Davies NM. Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opin Pharmacother 2005 6 : 2117 2140
49. Bendel O, Alkass K, Bueters T, von Euler M, von Euler G. Reproducible loss of CA1 neurons following carotid artery occlusion combined with halothane-induced hypotension. Brain Res 2005 1033 : 135 142
50. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 2005 33 : e56
51. Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999 399 : 75 80
52. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001 25 : 402 408
53. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951 193 : 265 275
54. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res 2005 81 : 302 313
55. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J, Shohami E. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 2005 19 : 1701 1703
56. Miyoshi R, Kito S, Doudou N, Nomoto T. Effect of age on alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites in the rat brain studied by in vitro autoradiography. Neurochem Res 1991 16 : 849 854
57. Tamaru M, Yoneda Y, Ogita K, Shimizu J, Nagata Y. Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res 1991 542 : 83 90
58. Wardas J, Pietraszek M, Schulze G, Ossowska K, Wolfarth S. Age-related changes in glutamate receptors: an autoradiographic analysis. Pol J Pharmacol 1997 49 : 401 410
59. Wenk GL, Barnes CA. Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat. Brain Res 2000 885 : 1 5
60. Pagliusi SR, Gerrard P, Abdallah M, Talabot D, Catsicas S. Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons? Neuroscience 1994 61 : 429 433
61. Paupard M, O'Connell MA, Gerber AP, Zukin RS. Patterns of developmental expression of the RNA editing enzyme rADAR2. Neuroscience 2000 95 : 869 879
62. Yau JL, Olsson T, Noble J, Seckl JR. Serotonin receptor subtype gene expression in the hippocampus of aged rats following chronic amitriptyline treatment. Brain Res Mol Brain Res 1999 70 : 282 287
63. Dos-Anjos S, Martinez-Villayandre B, Montori S, Regueiro-Purrinos MM, Gonzalo-Orden JM, Fernandez-Lopez A. Transient global ischemia in rat brain promotes different NMDA receptor regulation depending on the brain structure studied. Neurochem Int 2009 54 : 180 185
64. DeGracia DJ, Jamison JT, Szymanski JJ, Lewis MK. Translation arrest and ribonomics in post-ischemic brain: layers and layers of players. J Neurochem 2008 106 : 2288 2301
65. Gee CE, Benquet P, Raineteau O, Rietschin L, Kirbach SW, Gerber U. NMDA receptors and the differential ischemic vulnerability of hippocampal neurons. Eur J Neurosci 2006 23 : 2595 2603
66. Jamison JT, Kayali F, Rudolph J, Marshall M, Kimball SR, DeGracia DJ. Persistent redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death following global brain ischemia and reperfusion. Neuroscience 2008 154 : 504 520
67. Noh KM, Yokota H, Mashiko T, Castillo PE, Zukin RS, Bennett MV. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci U S A 2005 102 : 12230 12235